Mandate

Vinge has advised Amasten Fastighets AB in connection with a directed share issue

September 15, 2020 Capital Markets and Public M&A

Vinge has advised Amasten Fastighets AB (“Amasten”), a real estate company, in connection with a directed share issue whereby Amasten receives SEK 500 million in issue proceeds.

The subscription price was determined to SEK 7.30 per share through an accelerated book building process. The share issue was directed to selected Swedish and international investors. The main purpose of the share issue is to finance continued growth through acquisitions of investment properties and development projects.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, Malte St Cyr Ohm and Amanda M Johansson.

 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026